The weight-loss effects of GLP-1 drugs are making big changes in many industries, but the impact on Wall Street is likely to be negligible. Here’s why.
If you received an IRMAA determination letter that will raise your Medicare Part B or D premium, you can submit Form SSA-44 to have the premium reviewed.